• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION VICI VENOUS STENT SYSTEM; STENT, ILIAC VEIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION VICI VENOUS STENT SYSTEM; STENT, ILIAC VEIN Back to Search Results
Model Number H74916120100
Device Problems Fracture (1260); Obstruction of Flow (2423)
Patient Problem Insufficient Information (4580)
Event Date 09/18/2020
Event Type  Injury  
Event Description
On (b)(6) 2020 boston scientific vici venous stent 16mmx120mmx100cm left external iliac h74916120100 - lot 19120020, 16mmx90mmx100cm vici venous stent 16x90mmx100cm right external iliac h74916090100 - lot 19090051.On (b)(6) 2021 left stent occluded, venogram, lysis catheter, thrombectomy, on (b)(6) 2021 venogram, bs stent fracture, medtronic abre venous self expanding stent system 16mmx60mm ab9u16060090 - lot b078277, on (b)(6) 2021 venogram left.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VICI VENOUS STENT SYSTEM
Type of Device
STENT, ILIAC VEIN
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
MDR Report Key13141848
MDR Text Key283161584
Report NumberMW5106402
Device Sequence Number1
Product Code QAN
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 12/29/2021
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Expiration Date12/31/2022
Device Model NumberH74916120100
Device Catalogue NumberH74916120100
Device Lot Number19120020
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/30/2021
Patient Sequence Number1
Treatment
AMITRIPTYLINE 10MG; CLOPIDOGREL 75 MG ; ELIQUIS 5MG ; PHENAZOPYRIDINE 200 MG ; PLAVIX ; TYLENOL ; ZOLPIDEM 10 MG AS NEEDED ; ZYRTEC
Patient Outcome(s) Hospitalization; Disability;
Patient Age58 YR
Patient SexFemale
Patient Weight54 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-